Hyosung Chemical Corporation (KRX:298000)
South Korea · Delayed Price · Currency is KRW 38,900
0.00 (0.00%)
At close: Mar 16, 2026
Hyosung Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,340,718 | 2,452,220 | 2,623,269 | 2,878,558 | 2,519,965 |
Other Revenue | 0 | 0 | 0 | - | -0 |
| 2,340,718 | 2,452,220 | 2,623,269 | 2,878,558 | 2,519,965 | |
Revenue Growth (YoY) | -4.55% | -6.52% | -8.87% | 14.23% | 38.67% |
Cost of Revenue | 2,411,216 | 2,534,725 | 2,731,118 | 3,108,714 | 2,282,689 |
Gross Profit | -70,498 | -82,505 | -107,849 | -230,156 | 237,276 |
Selling, General & Admin | 64,301 | 71,330 | 78,898 | 77,479 | 73,583 |
Research & Development | 16,963 | 19,097 | 18,618 | 20,883 | 21,783 |
Amortization of Goodwill & Intangibles | 511 | 524 | 543 | 541 | 335 |
Other Operating Expenses | 2,374 | 1,358 | 1,499 | 1,334 | 1,380 |
Operating Expenses | 90,003 | 92,305 | 105,858 | 106,571 | 100,702 |
Operating Income | -160,500 | -174,810 | -213,707 | -336,727 | 136,574 |
Interest Expense | -108,100 | -177,589 | -172,989 | -101,105 | -34,161 |
Interest & Investment Income | 2,157 | 2,203 | 3,355 | 1,485 | 209 |
Currency Exchange Gain (Loss) | -32,090 | -5,505 | 2,048 | -18,023 | -10,515 |
Other Non Operating Income (Expenses) | -17,215 | 10,852 | -7,203 | 7,909 | 9,741 |
EBT Excluding Unusual Items | -315,749 | -344,849 | -388,496 | -446,461 | 101,848 |
Gain (Loss) on Sale of Investments | 796.43 | 231.89 | -3,372 | -1,690 | 325.81 |
Gain (Loss) on Sale of Assets | 549 | -4,531 | -4,653 | -100 | 198 |
Asset Writedown | -22,463 | - | - | - | - |
Pretax Income | -336,866 | -349,148 | -396,520 | -448,251 | 102,372 |
Income Tax Expense | -107,835 | -19,120 | -30,669 | -39,384 | 43,956 |
Earnings From Continuing Operations | -229,031 | -330,029 | -365,851 | -408,867 | 58,416 |
Earnings From Discontinued Operations | 555,059 | 4,304 | 18,938 | - | - |
Net Income to Company | 326,028 | -325,724 | -346,913 | -408,867 | 58,416 |
Minority Interest in Earnings | 67,069 | - | - | - | - |
Net Income | 393,098 | -325,724 | -346,913 | -408,867 | 58,416 |
Preferred Dividends & Other Adjustments | - | - | 2,075 | - | - |
Net Income to Common | 393,098 | -325,724 | -348,988 | -408,867 | 58,416 |
Shares Outstanding (Basic) | 5 | 4 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 5 | 4 | 3 | 3 | 3 |
Shares Change (YoY) | 35.91% | 9.97% | 2.90% | - | - |
EPS (Basic) | 80426.01 | -90574.02 | -106720.55 | -128663.67 | 18382.50 |
EPS (Diluted) | 80426.01 | -90574.02 | -106720.55 | -128663.67 | 18382.50 |
Free Cash Flow | -128,968 | -230,373 | -65,247 | -378,605 | -259,605 |
Free Cash Flow Per Share | -26386.30 | -64059.62 | -19952.53 | -119140.94 | -81693.38 |
Gross Margin | -3.01% | -3.36% | -4.11% | -7.99% | 9.42% |
Operating Margin | -6.86% | -7.13% | -8.15% | -11.70% | 5.42% |
Profit Margin | 16.79% | -13.28% | -13.30% | -14.20% | 2.32% |
Free Cash Flow Margin | -5.51% | -9.39% | -2.49% | -13.15% | -10.30% |
EBITDA | 22,607 | 46,143 | 31,564 | -48,851 | 329,219 |
EBITDA Margin | 0.97% | 1.88% | 1.20% | -1.70% | 13.06% |
D&A For EBITDA | 183,107 | 220,953 | 245,271 | 287,876 | 192,645 |
EBIT | -160,500 | -174,810 | -213,707 | -336,727 | 136,574 |
EBIT Margin | -6.86% | -7.13% | -8.15% | -11.70% | 5.42% |
Effective Tax Rate | - | - | - | - | 42.94% |
Advertising Expenses | 460 | 630 | 706 | 1,008 | 225 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.